Siren Appoints New Chief Financial Officer to Support Growth And Sales

Siren has announced that the company has appointed Philip Preuss as the company’s new Chief Financial Officer (CFO). The newly appointed CFO of the company, Philip Preuss has over 17 years of experience in managing both the medical device and financial services industry. In his new role, Philip Preuss will report directly to Co-Founder and Chief Executive Officer of Siren, Ran Ma.

The company’s first product included the temperature monitoring sock that is also approved by the FDA. The socks are wirelessly connected to the software application that allows the healthcare practitioners to detect early signs of diabetic foot ulcers.

Co-Founder and Chief Executive Officer of Siren, Ran Ma said, “With Siren gaining significant commercial traction, we are making key executive hires to support substantial growth going forward.”

“We are excited to have someone with Phil’s background in the important role of Chief Financial Officer, especially given his shared commitment to advancing patient care. Phil’s extremely well-rounded skill set, deep functional knowledge in strategy, business operations, and finance, and experience building a startup medical device company from inception to an initial public offering, really complements the existing core competencies of our leadership team,” Ran Ma further added in the statement.

Sharing his thoughts over the new appointment, Mr. Philip Preuss said, “Siren has a compelling combination of an innovative technology platform, a commercial-ready product with existing reimbursement, strong business model, excellent executive and Board leadership, and top tier investors.”

“Most importantly, the company has developed a product that helps patients at-risk of suffering the potentially devastating complications of a severe chronic disease through early detection and prevention. I am extremely excited to join a company that will make such a positive transformational impact on patient care,” Philip Preuss further added in the statement.

Leave a Reply

Your email address will not be published. Required fields are marked *